Antibiotic resistance patterns of coagulase-negative staphylococcus strains isolated from blood cultures of septicemic patients in Turkey

Microbiological Research

Volumn 164, Issue 4, 2009, Pages 404-410

  Koksal, F ^a   Yasar, H ^a   Samasti, M ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Antimicrobial resistance; Blood culture; Coagulase negative staphylococci (CoNS); Slime production

Indexed keywords

ACIDS; ANTIBIOTICS; BACTERIOLOGY; BLOOD; BONE CEMENT; INTENSIVE CARE UNITS;

ANTIBACTERIAL AGENT; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL RESISTANCE; BLOOD CULTURE; BLOOD SAMPLES; CIPROFLOXACIN; CLINDAMYCIN; COAGULASE-NEGATIVE STAPHYLOCOCCI (CONS); EPIDERMIDIS; FUSIDIC ACID; GLYCOPEPTIDES; ISTANBUL; METHICILLIN; RESISTANCE RATE; RESISTANCE RATIO; SLIME PRODUCTION; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; SULFAMETHOXAZOLE; TEICOPLANIN; TRIMETHOPRIM; VANCOMYCIN;

ACID RESISTANCE;

ANTIBIOTICS; BACTERIAL DISEASE; BLOOD; DRUG RESISTANCE; ENZYME; MICROBIAL ACTIVITY; SAMPLING; SPECIES OCCURRENCE;

EURASIA; TURKEY;

STAPHYLOCOCCUS; STAPHYLOCOCCUS AURICULARIS; STAPHYLOCOCCUS CAPITIS; STAPHYLOCOCCUS CHROMOGENES; STAPHYLOCOCCUS COHNII; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS; STAPHYLOCOCCUS LENTUS; STAPHYLOCOCCUS LUGDUNENSIS; STAPHYLOCOCCUS SAPROPHYTICUS; STAPHYLOCOCCUS SCHLEIFERI; STAPHYLOCOCCUS SIMULANS; STAPHYLOCOCCUS WARNERI; STAPHYLOCOCCUS XYLOSUS;

EID: 67650146082     PISSN: 09445013     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micres.2007.03.004     Document Type: Article

References (41)

1. Altoparlak U., Kadanali A., and Celebi S. Slime factor positivity in coagulase negative staphylococci isolated from nasal samples of hemodialysis patients. Int J Clin Pract 58 (2004) 1112-1114
2. Ammendolia M.G., Di Rosa R., Montanoro L., Arciola C.R., and Baldassari L. Slime production and expression of the slime associated antigen by staphylococcal clinical isolates. J Clin Microbiol 37 (1999) 3235-3238
3. Asrat D., and Amanuel Y.W. Prevalence and antibiotic susceptibility pattern of bacterial isolates from blood culture in Tikur Anbassa Hospital, Addis Ababa, Ethiopia. Ethiop Med J 39 (2001) 97-104
4. Bartoszewicz M., Nowicka J., and Przondo-Mordarska A. Selected features determine pathogenicity of Staphylococcus haemolyticus. Med Dosw Mikrobiol 55 (2003) 225-229
5. Bates D.W., Sands K., Miller E., et al. Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. J Infect Dis 176 (1997) 1538-1551
6. Boisson K., Thouverez M., Talon D., and Bertrand X. Characterisation of Coagulase-Negative Staphylococci Isolated from Blood Infections: Incidence, Susceptibility to Glycopeptides, and Molecular Epidemiology. Eur J Clin Microbiol Infect Dis 21 (2002) 660-665
7. Boneca I.G., and Chiosis G. Vancomycin resistance: occurrence, mechanisms and strategies to combat it. Expert Opin Ther Targets 7 (2003) 311-328
8. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin-United States. Morb Mortal Wkly Rep 26 (2002) 565-567
9. Centers for Disease Control and Prevention. Brief report: vancomycin-resistant Staphylococcus aureus-New York. Morb Mortal Wkly Rep 53 (2004) 322-323
10. Christensen G.D., Simpson W.A., Bisno A.L., et al. Adherence of slime producing strains of Stahpylococcus epidermidis to smooth surfaces. Infect Immun 37 (1992) 318
11. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement. CLSI document M100-S16. vol. 26-3; M7-A7, vol. 26-2; M2-A9, vol. 26-1. Wayne, PA. USA. 2006.
12. Comité de L'antibiogramme de la Société Française de Microbiologie Communiqué. Pathol Biol. 1998;46:1-16.
13. Coutant C., Olden D., Bell J., and Turnidge J.D. Disk Diffusion Interpretive Criteria for Fusidic Acid Susceptibility Testing of Staphylococci by the National Committee for Clinical Laboratory Standards Method. Diagn Microbiol Infect Dis 25 (1996) 9-13
14. Davenport D.S., Massarani R.M., Pfaller M.A., et al. Usefullness of a test for slime production as a marker for clinically significant infecting with coagulase negative Staphylococci. J Infect Dis 153 (1986) 332-339
15. Deighton M.A., Franklin J.C., Spicer W.J., and Balkau B. Species identification, antibiotic sensitivity and slime production of coagulase-negative staphylococci isolated from clinical specimens. Epidemiol Infect 101 (1988) 99-113
16. Diaz-Mitoma F.G., Harding G.K.M., Hoban D.J., Roberts R.S., and Low D.E. Clinical significance of a test for slime production in ventriculoperitoneal shunts infections with coagulase negative staphylococci. J Infect Dis 156 (1987) 555-560
17. Drozenova J., and Petras P. Characteristics of coagulase-negative staphylococci isolated from hemocultures. Epidemiol, Mikrobiol, Imunol 49 (2000) 51-58
18. Ertek M., Yazgi H., and Erol S. Demonstration of in vitro antagonism between fusidic acid and quinolones. J Int Med Res 30 (2002) 525-528
19. Freeman D.J., Falkiner F.R., and Keane C.T. New method for detecting slime production by coagulase negative staphylococci. J Clin Pathol 42 (1989) 872-874
20. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 16 (1988) 128-140
21. Gristina A.G., Jennings R.A., Naylor P.T., et al. Comperative in vitro antibiotic resistance of surface colonizing coagulase negative Staphylococci. Antimicrob Chemother 33 (1989) 813-816
22. Herwaldt L.A., Geiss M., Kao C., and Pfaller M.A. The positive predictive value of isolating coagulase-negative staphylococci from blood cultures. Clin Infect Dis 22 (1996) 14-20
23. Hiramatsu K., Hanaki H., Ino T., Yabuta K., Oguri T., and Tenover F.C. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40 (1997) 135-136
24. Huang S.Y., Tang R.N., Chen S.Y., et al. Coagulase-negative staphylococcal bacteremia in critically ill children: risk factors and antimicrobial susceptibility. J Microbiol Immunol Infect 36 (2003) 51-55
25. Jain A., Agarwa J., and Bansal S. Prevalence of methicillin-resistant, coagulase-negative staphylococci in neonatal intensive care units: findings from a tertiary care hospital in India. J Med Microbiol 53 (2004) 941-944
26. Jones M.E., Sader H.S., Verhoef J., Acar J., and Jones R.N. Current state of susceptibility to glycopeptides in Staphylococcus species from an international resistance surveillance program. J Antimicrob Chemother 42 (1998) 119-121
27. Klingenberg C., Sundsfjord A., Rønnestad A., Mikalsen J., Gaustad P., and Flægstad T. Phenotypic and genotypic aminoglycoside resistance in blood culture isolates of coagulase-negative staphylococci from a single neonatal intensive care unit, 1989-2000. J Antimicrob Chemother 54 (2004) 889-896
28. Knauer A., Fladerer P., and Strempfl C. Effect of hospitalization and antimicrobial therapy on bantimicrobial resistance of colonizing Staphylococcus epidermidis. Wien Klin Wochenschr 116 (2004) 489-494
29. Koksal F, Ozturk R, Ayar E, et al. Antimicrobial susceptibility of Gram positive bacteria isolated from blood cultures. Tenth Mediterranean Congress of Chemotherapy. Antalya-Turkey: 1996.
30. Livermore D.M. Antibiotic resistance in staphylococci. Int J Antimicrob Agents 16 (2000) S3-S10
31. Ludwicka A., Uhlenbruck G., Peters G., et al. Investigation on extracellular slime substance produced by Staphylococcus epidermidis. Zentralhl Bakteriol Hyg A 258 (1984) 256-267
32. Malm A., Biernasiuk A., Los R., Kosikowska U., Juda M., Korona-Glowniak I., et al. Slime production and cell surface hydrophobicity of nasopharyngeal and skin staphylococci isolated from healthy people. Pol J Microbiol 54 (2005) 117-121
33. Mandell G.L., Bennett J.E., and Dolin R. Mandell, Dauglas and, Bennett's Principles and Practice of Infectious Diseases. 5th ed (2000), Churchill Livingstone Inc, Philadelphia [p. 2069]
34. Mayhall C.G. Hospital epidemiology and infection control. 3rd ed (2004), Lippincott Wiliam and Wilkins, Philadelphia [p. 495-510]
35. Murray PR, Baron EJ, Jorgensen JH, et al. Manual of Clinical Microbiology. Vol. 1. 8th ed. Washington, DC: 2003. p. 304-404.
36. Oto S., Aydin P., Ciftcioglu N., and Dursun D. Slime production by coagulase-negative staphylococci isolated in chronic blepharitis. Eur J Ophthalmol 8 (1998) 1-3
37. Palazzo I.C.V., Araujo M.L.C., and Darini A.L.C. First report of vancomycin-resistant Staphylococci isolated from healthy carriers in Brazil. J Clin Microbiol 43 (2005) 179-185
38. Sakarya S., Oncu S., Ozturk B., et al. Nouraminidase produces dose-dependent decrease of slime production and adherence of slime-forming, coagulase-negative staphylococci. Arch Med Res 35 (2004) 275-278
39. Skov R., Frimodt-Møller N., and Espersen F. Tentative interpretative zone diameters for fusidic Neosensitabs† on Mueller Hinton agar and three blood media. Int J Antimicrob Agents 22 (2003) 502-507
40. Udo E.E., Jacob L.E., and Chugh T.D. Antimicrobial resistance of coagulase-negative staphylococci from a Kuwait hospital. Microb Drug Resist 1 (1995) 315-320
41. Winn WC, Allen SD, Janda WM, Koneman EW, Procop GW, Schreckenberger PC, Woods GL. Koneman's Color Atlas and Textbook of Diagnostic Microbiology. 6th ed. Philadelphia: 2006.